We work with cells and tissues taken directly from patients. These are limited and precious resources and we need a way to efficiently and rapidly quality check them before doing our experiments. The Agilent Bioanalyzer purchased for the lab by Cure Cancer is a highly sensitive device that does just this. For us, it is an indispensable piece of equipment used throughout the whole process of preparing patient samples for next-generation sequencing (NGS), which helps us uncover new therapies for lymphoma.
Dr Elitza Deltcheva, post-doctoral researcher